AUA 2018 - Results from #180

Viewing 181-200 of 364 articles

AUA 2018: Outcomes and Factors Associated with Receipt of Open vs Minimally Invasive RPLND for Testis Cancer

AUA 2018: Salvage High-Intensity Focused Ultrasound For Locally Recurrent Prostate Cancer after Low-Dose-Rate Brachytherapy: Oncologic and Functional Outcomes

AUA 2018: Efficacy and Safety of Add-on Mirabegron vs Placebo to Tamsulosin in Men with Overactive Bladder Symptoms MATCH Study

AUA 2018: Insomnia Induces Lower Urinary Tract Symptoms: The Natural History and Risk Factors for LUTS from the Nagahama Longitudinal Study

AUA 2018: Extended First Uninterrupted Sleep Period in Elderly Patients Following Treatment with AV002, an Emulsified Low Dose Vasopressin Analog for Nocturia

AUA 2018: Crowdsourcing Robotics

AUA 2018: Complex Cases: Locally Advanced and Metastatic Kidney Cancer

AUA 2018: Phase II Clinical Trial in Prostate Cancer Evaluating 68Ga-PSMA-11 Detection on both Preoperative PET-CT and Immediate Postoperative Specimen Scanning

AUA 2018: Patient Reported Outcomes in SPARTAN, a Phase 3, Double-Blind, Randomized Study of Apalutamide plus ADT vs placebo plus ADT in Men with nmCRPC

AUA 2018: Outcomes of Synchronous and Metachronous Bilateral Small Renal Masses (4cm)

AUA 2018: Long-Term Active Surveillance of Complex Cystic Renal Masses & the Heterogeneity of BOSNIAK 3 Lesions

AUA 2018: MRI Imaging - AUA Statement on its Use for Diagnosis, Staging, and Management

AUA 2018: Prostate Cancer: What PET to GET?

AUA 2018: Controversies in Urology: Kidney Cancer – Treatment with Thermal Ablation – CON

AUA 2018: Controversies in Urology: Kidney Cancer – Treatment with Thermal Ablation – CON Rebuttal

AUA 2018: Controversies in Urology: Kidney Cancer – Treatment with Thermal Ablation – PRO Rebuttal

AUA 2018: Controversies in Urology: Kidney Cancer – Treatment with Thermal Ablation – PRO

AUA 2018: Can Active Surveillance Really Reduce the Harms of PSA Testing? PRIAS-Study Implicates Caution

AUA 2018: Phase 3 Study of Vicinium in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: Initial Results

AUA 2018: Results of CALIBER: A Phase II Randomized Feasibility Trial of Chemoablation vs Surgical Management in Low Risk Non-Muscle Invasive Bladder Cancer

5
6
7
8
9
10
11
12
13
14